# COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19

> **NCT04328012** · PHASE2,PHASE3 · TERMINATED · sponsor: **Bassett Healthcare** · enrollment: 15 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** Losartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04328012
- **Lead sponsor:** Bassett Healthcare
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-06
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** difficult enrollment
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328012, "COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04328012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*